Dentium 2026H1: Dental Profit Approximately RMB 77.01 Million, Down 38.22%, China’s Share of Total Revenue Rises to 44.7%

Source: Dentium 2026 Interim Report

DentalGoodNews｜August 14 - Dentium (Dentium) released its semi-annual report for 2026. Data shows that the company's consolidated revenue for H1 2026 (January-June) was KRW 160.729 billion (approximately RMB 771 million), up 1.03% year-on-year; Net Profit Attributable to Shareholders of the Parent Company was KRW 31.109 billion (approximately RMB 149 million), up 78.84% year-on-year; consolidated Operating Profit was KRW 30.539 billion (approximately RMB 147 million), up 21.55% year-on-year.

Source: Dentium 2026 Interim Report

Segment data shows that the company's core dental business recorded an Operating Profit of KRW 16.043 billion (approximately RMB 77.006 million) in H1, down 38.22% from KRW 25.969 billion (approximately RMB 125 million) in the same period last year; the hydrogen fuel cell business, newly expanded in 2024, posted an operating loss of KRW 4.236 billion (approximately RMB 20.333 million) in H1, widening from a loss of KRW 1.983 billion (approximately RMB 9.518 million) in the same period last year. The combined Operating Profit of the two businesses was KRW 11.807 billion (approximately RMB 56.674 million), which differs from the consolidated Operating Profit of KRW 30.539 billion (approximately RMB 147 million), with the difference recorded under consolidated elimination adjustments. This item rose from KRW 1.139 billion (approximately RMB 5.467 million) in the same period last year to KRW 18.733 billion (approximately RMB 89.918 million).

Source: Dentium 2026 Interim Report

By region, the Chinese market contributed KRW 71.862 billion (approximately RMB 345 million) in revenue during H1, accounting for 44.7% of consolidated revenue, a notable increase from the 38.3% share recorded for the full year 2025; the domestic Korean market accounted for 18.8%, and the European market 16.2%.

In addition, the company's financial income grew significantly year-on-year in H1. The semi-annual report shows financial income of KRW 19.477 billion (approximately RMB 93.49 million), up 400.54% from KRW 3.891 billion (approximately RMB 18.677 million) in the same period last year; among which, foreign exchange translation gains increased from KRW 1.624 billion (approximately RMB 7.795 million) to KRW 12.811 billion (approximately RMB 61.493 million).

In terms of financial activities, the company cancelled 2.4449 million treasury shares during H1, and signed a treasury share trust contract with NH Investment & Securities on April 1 for KRW 60 billion (approximately RMB 288 million), during which it purchased 359,000 uncancelled treasury shares for KRW 17.365 billion (approximately RMB 83.352 million). According to previous reports by DGN, Dentium faced a management rights dispute lawsuit initiated by shareholder Align Partners Asset Management in 2025. The semi-annual report discloses that the court has dismissed Align Partners' application for a preliminary injunction against the performance of duties by one independent director, but the lawsuit seeking revocation of the shareholders' meeting resolution filed by Align Partners remains under first-instance trial.